UTHR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $147,331,349.97

United Therapeutics Insider Trading History Chart

United Therapeutics Share Price & Price History

^$316.34

▼ -4.03 (-1.26%)

As of 05/30/2025 05:00 PM ET

Days: 30 | 90 | 365

United Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/29/2025	Paul A. Mahon	EVP	Sell	11,000	$316.07	$3,476,770.00	36,781
5/1/2025	Paul A. Mahon	EVP	Sell	11,000	$300.93	$3,310,230.00	36,781
4/21/2025	Raymond A. Dwek	Director	Sell	3,000	$285.57	$856,710.00	1,750
4/17/2025	Paul A. Mahon	EVP	Sell	11,000	$283.78	$3,121,580.00	36,781
4/14/2025	Raymond A. Dwek	Director	Sell	3,000	$285.16	$855,480.00	1,750
4/7/2025	Raymond A. Dwek	Director	Sell	4,000	$284.55	$1,138,200.00	1,750
4/3/2025	Paul A. Mahon	EVP	Sell	11,000	$306.18	$3,367,980.00	36,781
3/24/2025	Tommy G. Thompson	Director	Sell	2,500	$318.80	$797,000.00	8,480
2/24/2025	Michael Benkowitz	COO	Sell	10,000	$360.76	$3,607,600.00	2,577
2/18/2025	Michael Benkowitz	COO	Sell	10,000	$371.05	$3,710,500.00	2,577
2/10/2025	Michael Benkowitz	COO	Sell	10,000	$348.06	$3,480,600.00	2,577
2/3/2025	Michael Benkowitz	COO	Sell	10,000	$353.64	$3,536,400.00	2,577
1/27/2025	Michael Benkowitz	COO	Sell	10,000	$370.71	$3,707,100.00	2,577
1/21/2025	Michael Benkowitz	COO	Sell	10,000	$364.91	$3,649,100.00	2,577
1/13/2025	Michael Benkowitz	COO	Sell	10,000	$364.62	$3,646,200.00	2,577
12/30/2024	Michael Benkowitz	COO	Sell	10,000	$356.68	$3,566,800.00	2,577
12/30/2024	Nilda Mesa	Director	Sell	255	$355.77	$90,721.35	5,528
12/23/2024	Michael Benkowitz	COO	Sell	10,000	$361.95	$3,619,500.00	2,577
12/18/2024	Louis W. Sullivan	Director	Sell	26,209	$373.22	$9,781,722.98	5,051
12/5/2024	Paul A. Mahon	EVP	Sell	7,700	$374.37	$2,882,649.00	36,710
11/25/2024	Michael Benkowitz	COO	Sell	10,000	$372.75	$3,727,500.00	2,577
11/21/2024	Paul A. Mahon	EVP	Sell	7,700	$367.36	$2,828,672.00	36,710
11/11/2024	Judy D. Olian	Director	Sell	1,750	$412.48	$721,840.00	5,655
11/11/2024	Michael Benkowitz	COO	Sell	15,000	$407.32	$6,109,800.00
11/8/2024	Nilda Mesa	Director	Sell	224	$412.28	$92,350.72	5,783
11/7/2024	Michael Benkowitz	COO	Sell	15,000	$401.44	$6,021,600.00	2,577
11/1/2024	Christopher Causey	Director	Sell	510	$376.63	$192,081.30	3,675
11/1/2024	Michael Benkowitz	COO	Sell	14,700	$374.46	$5,504,562.00	2,577
10/28/2024	James Edgemond	CFO	Sell	7,800	$350.00	$2,730,000.00	6,978
10/21/2024	James Edgemond	CFO	Sell	7,782	$366.99	$2,855,916.18	6,426
10/14/2024	James Edgemond	CFO	Sell	7,792	$355.88	$2,773,016.96	5,884
10/7/2024	James Edgemond	CFO	Sell	7,794	$355.54	$2,771,078.76	5,344
9/30/2024	James Edgemond	CFO	Sell	7,792	$358.62	$2,794,367.04	4,802
9/23/2024	James Edgemond	CFO	Sell	7,796	$354.04	$2,760,095.84	4,264
9/9/2024	James Edgemond	CFO	Sell	7,802	$345.41	$2,694,888.82	3,210
9/3/2024	James Edgemond	CFO	Sell	7,785	$362.37	$2,821,050.45	2,615
8/26/2024	Martine A Rothblatt	CEO	Sell	269	$348.41	$93,722.29	130
8/19/2024	Martine A Rothblatt	CEO	Sell	3,600	$344.18	$1,239,048.00	130
8/8/2024	Martine A Rothblatt	CEO	Sell	3,600	$328.39	$1,182,204.00	130
8/7/2024	Michael Benkowitz	COO	Sell	25,000	$323.38	$8,084,500.00	2,577
8/6/2024	Martine A Rothblatt	CEO	Sell	3,600	$325.45	$1,171,620.00	130
8/2/2024	Martine A Rothblatt	CEO	Sell	3,600	$324.73	$1,169,028.00	130
8/2/2024	Raymond A. Dwek	Director	Sell	5,000	$325.35	$1,626,750.00	1,750
7/30/2024	Martine A Rothblatt	CEO	Sell	3,600	$337.40	$1,214,640.00	130
7/26/2024	Martine A Rothblatt	CEO	Sell	3,600	$338.61	$1,218,996.00	130
7/24/2024	Martine A Rothblatt	CEO	Sell	3,600	$334.00	$1,202,400.00	130
7/22/2024	Martine A Rothblatt	CEO	Sell	3,600	$331.32	$1,192,752.00	130
7/18/2024	Martine A Rothblatt	CEO	Sell	3,600	$331.79	$1,194,444.00	130
7/16/2024	Martine A Rothblatt	CEO	Sell	3,600	$328.03	$1,180,908.00	130
7/12/2024	Martine A Rothblatt	CEO	Sell	3,600	$324.97	$1,169,892.00	130
7/10/2024	Martine A Rothblatt	CEO	Sell	3,600	$326.35	$1,174,860.00	130
7/8/2024	Martine A Rothblatt	CEO	Sell	3,600	$317.05	$1,141,380.00	130
7/5/2024	Martine A Rothblatt	CEO	Sell	3,600	$313.25	$1,127,700.00	130
7/3/2024	Martine A Rothblatt	CEO	Sell	3,600	$312.48	$1,124,928.00	130
7/1/2024	Martine A Rothblatt	CEO	Sell	3,600	$320.45	$1,153,620.00	130
6/27/2024	Martine A Rothblatt	CEO	Sell	3,600	$316.62	$1,139,832.00	130
6/25/2024	Nilda Mesa	Director	Sell	266	$318.58	$84,742.28	5,107
6/24/2024	Martine A Rothblatt	CEO	Sell	3,600	$315.97	$1,137,492.00	130
6/21/2024	Martine A Rothblatt	CEO	Sell	3,600	$313.91	$1,130,076.00	130
6/14/2024	Martine A Rothblatt	CEO	Sell	3,600	$287.22	$1,033,992.00	130
6/13/2024	Christopher Causey	Director	Sell	2,000	$281.53	$563,060.00	4,185
6/12/2024	Martine A Rothblatt	CEO	Sell	3,600	$281.19	$1,012,284.00	130
6/10/2024	Martine A Rothblatt	CEO	Sell	3,600	$273.95	$986,220.00	130
6/7/2024	Martine A Rothblatt	CEO	Sell	3,600	$277.13	$997,668.00	130
5/31/2024	Martine A Rothblatt	CEO	Sell	3,600	$272.48	$980,928.00	130
5/28/2024	Martine A Rothblatt	Director	Sell	3,600	$269.06	$968,616.00	130
5/23/2024	Martine A Rothblatt	Director	Sell	3,600	$275.78	$992,808.00	130
5/21/2024	Martine A Rothblatt	Director	Sell	1,468	$275.85	$404,947.80	130
5/16/2024	Martine A Rothblatt	Director	Sell	3,600	$272.37	$980,532.00	130
5/14/2024	Christopher Patusky	Director	Sell	1,310	$264.35	$346,298.50
5/13/2024	Martine A Rothblatt	CEO	Sell	3,600	$265.48	$955,728.00	130
5/9/2024	Martine A Rothblatt	CEO	Sell	3,600	$264.22	$951,192.00	130
5/6/2024	Martine A Rothblatt	CEO	Sell	3,600	$259.70	$934,920.00	130
5/3/2024	Christopher Causey	Director	Sell	2,240	$259.91	$582,198.40	4,185
5/2/2024	Martine A Rothblatt	CEO	Sell	3,600	$258.09	$929,124.00	130
4/30/2024	Martine A Rothblatt	CEO	Sell	3,600	$235.35	$847,260.00	130
4/26/2024	Martine A Rothblatt	CEO	Sell	3,600	$235.20	$846,720.00	130
4/24/2024	Martine A Rothblatt	CEO	Sell	3,600	$238.81	$859,716.00	130
4/22/2024	Martine A Rothblatt	CEO	Sell	3,600	$236.47	$851,292.00	130
4/18/2024	Martine A Rothblatt	CEO	Sell	3,600	$237.91	$856,476.00	130
4/16/2024	Martine A Rothblatt	CEO	Sell	3,600	$232.05	$835,380.00	130
4/12/2024	Martine A Rothblatt	CEO	Sell	3,600	$235.42	$847,512.00	130
4/10/2024	Martine A Rothblatt	CEO	Sell	13,800	$237.27	$3,274,326.00	130
4/8/2024	Martine A Rothblatt	CEO	Sell	5,060	$237.52	$1,201,851.20	130
4/4/2024	Martine A Rothblatt	CEO	Sell	15,000	$233.27	$3,499,050.00	130
4/4/2024	Paul A. Mahon	EVP	Sell	6,000	$232.37	$1,394,220.00	36,710
3/28/2024	Martine A Rothblatt	CEO	Sell	14,125	$236.18	$3,336,042.50	130
3/27/2024	Nilda Mesa	Director	Sell	325	$237.80	$77,285.00	5,373
3/26/2024	Martine A Rothblatt	CEO	Sell	15,000	$248.33	$3,724,950.00	130
3/22/2024	Martine A Rothblatt	CEO	Sell	15,000	$237.05	$3,555,750.00	130
3/21/2024	Paul A. Mahon	EVP	Sell	6,000	$236.45	$1,418,700.00	36,710
3/19/2024	Martine A Rothblatt	CEO	Sell	15,000	$236.59	$3,548,850.00	130
2/23/2024	Christopher Patusky	Director	Sell	1,680	$224.00	$376,320.00	4
2/15/2024	Paul A. Mahon	EVP	Sell	6,000	$215.31	$1,291,860.00	36,599
2/1/2024	Paul A. Mahon	EVP	Sell	6,000	$215.01	$1,290,060.00	36,599
1/18/2024	Paul A. Mahon	EVP	Sell	6,000	$218.72	$1,312,320.00	36,599
1/4/2024	Paul A. Mahon	EVP	Sell	6,000	$227.97	$1,367,820.00	36,599
12/21/2023	Paul A. Mahon	EVP	Sell	6,000	$229.27	$1,375,620.00	36,599
12/19/2023	Nilda Mesa	Director	Sell	605	$244.90	$148,164.50	5,698
12/12/2023	Christopher Causey	Director	Sell	3,000	$249.68	$749,040.00	4,585
12/7/2023	Paul A. Mahon	EVP	Sell	6,000	$238.89	$1,433,340.00	36,599
11/2/2023	Paul A. Mahon	EVP	Sell	6,000	$225.76	$1,354,560.00	36,599
10/19/2023	Paul A. Mahon	EVP	Sell	6,000	$225.43	$1,352,580.00	36,599
10/5/2023	Paul A. Mahon	EVP	Sell	6,000	$223.82	$1,342,920.00	36,599
9/21/2023	Paul A. Mahon	EVP	Sell	6,000	$222.19	$1,333,140.00	36,599
9/13/2023	Nilda Mesa	Director	Sell	383	$222.36	$85,163.88	6,303
9/7/2023	Paul A. Mahon	EVP	Sell	6,000	$222.98	$1,337,880.00	36,599
8/3/2023	Paul A. Mahon	EVP	Sell	6,000	$236.25	$1,417,500.00	36,599
7/20/2023	Paul A. Mahon	EVP	Sell	2,500	$243.87	$609,675.00	36,599
7/6/2023	Paul A. Mahon	EVP	Sell	6,000	$215.19	$1,291,140.00	36,599
6/15/2023	Paul A. Mahon	EVP	Sell	6,000	$227.77	$1,366,620.00	36,599
6/1/2023	Paul A. Mahon	EVP	Sell	6,000	$209.11	$1,254,660.00	36,599
5/18/2023	Paul A. Mahon	EVP	Sell	6,000	$214.58	$1,287,480.00	36,599
5/5/2023	Nilda Mesa	Director	Sell	374	$214.81	$80,338.94	5,806
5/4/2023	Paul A. Mahon	EVP	Sell	6,000	$215.82	$1,294,920.00	36,599
5/1/2023	Martine A Rothblatt	CEO	Sell	8,000	$231.40	$1,851,200.00	130
4/28/2023	Martine A Rothblatt	CEO	Sell	8,000	$229.32	$1,834,560.00	130
4/26/2023	Martine A Rothblatt	CEO	Sell	8,000	$226.01	$1,808,080.00	130
4/24/2023	Martine A Rothblatt	CEO	Sell	8,000	$228.64	$1,829,120.00	130
4/21/2023	Martine A Rothblatt	CEO	Sell	8,000	$228.82	$1,830,560.00	130
4/20/2023	Christopher Patusky	Director	Buy	6	$114.06	$684.36	1,686
4/20/2023	Paul A. Mahon	EVP	Sell	6,000	$223.96	$1,343,760.00	36,599
4/19/2023	Martine A Rothblatt	CEO	Sell	8,000	$226.12	$1,808,960.00	130
4/17/2023	Martine A Rothblatt	CEO	Sell	8,000	$230.47	$1,843,760.00	130
4/13/2023	Martine A Rothblatt	CEO	Sell	8,000	$230.69	$1,845,520.00	130
4/11/2023	Martine A Rothblatt	CEO	Sell	8,000	$225.57	$1,804,560.00	130
4/6/2023	Martine A Rothblatt	CEO	Sell	8,000	$229.12	$1,832,960.00	130
4/6/2023	Paul A. Mahon	EVP	Sell	6,000	$232.79	$1,396,740.00	36,599
4/4/2023	Martine A Rothblatt	CEO	Sell	8,000	$226.26	$1,810,080.00	130
3/30/2023	Martine A Rothblatt	CEO	Sell	8,000	$217.14	$1,737,120.00	130
3/27/2023	Martine A Rothblatt	CEO	Sell	8,000	$217.04	$1,736,320.00	130
3/24/2023	Martine A Rothblatt	CEO	Sell	8,000	$217.95	$1,743,600.00	130
3/22/2023	Martine A Rothblatt	CEO	Sell	8,000	$216.01	$1,728,080.00	130
3/20/2023	Christopher Patusky	Director	Sell	5	$107.71	$538.55	1,680
3/20/2023	Martine A Rothblatt	CEO	Sell	8,000	$223.96	$1,791,680.00	130
3/17/2023	Martine A Rothblatt	CEO	Sell	8,000	$217.91	$1,743,280.00	130
3/16/2023	Paul A. Mahon	EVP	Sell	6,000	$214.39	$1,286,340.00	36,599
3/9/2023	Martine A Rothblatt	CEO	Sell	8,000	$222.63	$1,781,040.00	130
3/7/2023	Martine A Rothblatt	CEO	Sell	8,000	$239.16	$1,913,280.00	121
3/2/2023	Martine A Rothblatt	CEO	Sell	8,000	$244.50	$1,956,000.00	130
2/27/2023	Martine A Rothblatt	CEO	Sell	8,000	$249.14	$1,993,120.00	130
2/24/2023	Martine A Rothblatt	CEO	Sell	8,000	$249.27	$1,994,160.00	130
2/22/2023	Martine A Rothblatt	CEO	Sell	8,000	$246.77	$1,974,160.00	130
2/13/2023	Martine A Rothblatt	CEO	Sell	8,000	$254.76	$2,038,080.00	130
2/8/2023	Martine A Rothblatt	CEO	Sell	8,000	$253.38	$2,027,040.00	130
2/2/2023	Paul A. Mahon	EVP	Sell	6,000	$254.63	$1,527,780.00	36,397
2/1/2023	Louis W. Sullivan	Director	Sell	700	$261.33	$182,931.00	12,180
1/31/2023	Martine A Rothblatt	CEO	Sell	8,000	$261.50	$2,092,000.00	130
1/27/2023	Martine A Rothblatt	CEO	Sell	8,000	$260.01	$2,080,080.00	130
1/25/2023	Martine A Rothblatt	CEO	Sell	8,000	$264.21	$2,113,680.00	130
1/23/2023	Martine A Rothblatt	CEO	Sell	8,000	$258.97	$2,071,760.00	130
1/19/2023	Martine A Rothblatt	CEO	Sell	8,000	$259.60	$2,076,800.00	130
1/19/2023	Paul A. Mahon	EVP	Sell	6,000	$258.95	$1,553,700.00	36,397
1/17/2023	Martine A Rothblatt	CEO	Sell	8,000	$260.50	$2,084,000.00	130
1/13/2023	Martine A Rothblatt	CEO	Sell	8,000	$261.52	$2,092,160.00	130
1/11/2023	Martine A Rothblatt	CEO	Sell	8,000	$261.39	$2,091,120.00	130
1/9/2023	Martine A Rothblatt	CEO	Sell	8,000	$267.86	$2,142,880.00	130
1/6/2023	Martine A Rothblatt	CEO	Sell	8,000	$276.29	$2,210,320.00	130
1/3/2023	Louis W. Sullivan	Director	Sell	700	$276.26	$193,382.00	12,180
12/27/2022	Martine A Rothblatt	CEO	Sell	8,000	$274.34	$2,194,720.00	130
12/23/2022	Martine A Rothblatt	CEO	Sell	8,000	$277.61	$2,220,880.00	130
12/20/2022	Martine A Rothblatt	CEO	Sell	8,000	$272.20	$2,177,600.00	130
12/15/2022	Paul A. Mahon	EVP	Sell	12,000	$196.31	$2,355,720.00	36,397
12/14/2022	Martine A Rothblatt	CEO	Sell	6,310	$276.75	$1,746,292.50	130
12/12/2022	Martine A Rothblatt	CEO	Sell	8,000	$279.27	$2,234,160.00	130
12/9/2022	Judy D. Olian	Director	Sell	1,010	$282.00	$284,820.00	7,655
12/8/2022	Martine A Rothblatt	CEO	Sell	8,000	$278.65	$2,229,200.00	130
12/6/2022	Martine A Rothblatt	CEO	Sell	8,000	$274.29	$2,194,320.00	130
12/1/2022	Louis W. Sullivan	Director	Sell	700	$279.89	$195,923.00	12,180
12/1/2022	Paul A. Mahon	EVP	Sell	6,000	$277.65	$1,665,900.00	36,397
11/30/2022	Martine A Rothblatt	CEO	Sell	8,000	$277.53	$2,220,240.00	130
11/28/2022	Martine A Rothblatt	CEO	Sell	8,000	$270.07	$2,160,560.00	130
11/25/2022	Martine A Rothblatt	CEO	Sell	8,000	$267.26	$2,138,080.00	130
11/23/2022	Martine A Rothblatt	CEO	Sell	8,000	$268.56	$2,148,480.00	130
11/21/2022	Martine A Rothblatt	CEO	Sell	8,000	$266.93	$2,135,440.00	130
11/18/2022	Martine A Rothblatt	CEO	Sell	8,000	$263.97	$2,111,760.00	130
11/14/2022	Martine A Rothblatt	CEO	Sell	8,000	$258.17	$2,065,360.00	130
11/8/2022	Martine A Rothblatt	CEO	Sell	7,680	$262.70	$2,017,536.00	130
11/7/2022	Nilda Mesa	Director	Sell	290	$268.57	$77,885.30	6,180
11/4/2022	Martine A Rothblatt	CEO	Sell	8,000	$264.85	$2,118,800.00	130
11/3/2022	Paul A. Mahon	EVP	Sell	6,000	$257.08	$1,542,480.00	36,397
11/1/2022	Louis W. Sullivan	Director	Sell	700	$230.28	$161,196.00	12,180
10/20/2022	Paul A. Mahon	EVP	Sell	6,000	$216.68	$1,300,080.00	36,397
10/6/2022	Paul A. Mahon	EVP	Sell	6,000	$209.26	$1,255,560.00	36,397
10/3/2022	Louis W. Sullivan	Director	Sell	710	$211.56	$150,207.60	12,180
9/28/2022	Nilda Mesa	Director	Sell	850	$211.05	$179,392.50	6,870
9/22/2022	Paul A. Mahon	EVP	Sell	6,000	$203.34	$1,220,040.00	36,397
8/23/2022	Christopher Causey	Director	Sell	3,500	$224.96	$787,360.00	2,835
8/4/2022	Paul A. Mahon	EVP	Sell	4,552	$225.81	$1,027,887.12	36,397
7/21/2022	Paul A. Mahon	EVP	Sell	6,000	$226.27	$1,357,620.00	36,397
7/11/2022	Raymond A. Dwek	Director	Sell	2,160	$241.29	$521,186.40
7/7/2022	Paul A. Mahon	EVP	Sell	6,000	$242.04	$1,452,240.00	36,397
6/27/2022	Christopher Causey	Director	Sell	5,000	$236.79	$1,183,950.00	675
6/16/2022	Paul A. Mahon	EVP	Sell	6,000	$215.58	$1,293,480.00	36,397
5/31/2022	Martine A Rothblatt	CEO	Sell	3,000	$230.85	$692,550.00	130
5/27/2022	Martine A Rothblatt	CEO	Sell	3,000	$231.27	$693,810.00	130

See Full Table

SEC Filings (Institutional Ownership Changes) for United Therapeutics (NASDAQ:UTHR)

94.08% of United Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

United Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/27/2025	Advisors Capital Management LLC	1,030	$0.32M	0.0%	-4.2%	0.002%
5/21/2025	Acadian Asset Management LLC	179,205	$55.22M	0.2%	+1,657.8%	0.397%
5/21/2025	Geneos Wealth Management Inc.	145	$45K	0.0%	+141.7%	0.000%
5/21/2025	IFM Investors Pty Ltd	7,990	$2.46M	0.0%	-2.5%	0.018%
5/20/2025	Intech Investment Management LLC	30,935	$9.54M	0.1%	+1.4%	0.069%
5/20/2025	Focus Partners Wealth	1,458	$0.45M	0.0%	-23.9%	0.003%
5/20/2025	Capital Impact Advisors LLC	21,112	$6.51M	2.5%	N/A	0.047%
5/20/2025	Plato Investment Management Ltd	1,786	$0.56M	0.0%	-8.4%	0.004%
5/19/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	257,662	$79.43M	0.0%	+10.9%	0.571%
5/16/2025	Empowered Funds LLC	57,975	$17.87M	0.3%	+169.3%	0.129%
5/16/2025	Ascent Group LLC	718	$0.22M	0.0%	+7.6%	0.002%
5/16/2025	Axiom Investors LLC DE	1,621	$0.50M	0.0%	-83.9%	0.004%
5/16/2025	United Services Automobile Association	2,855	$0.88M	0.0%	N/A	0.006%
5/16/2025	Great Lakes Advisors LLC	2,492	$0.77M	0.0%	+26.2%	0.006%
5/16/2025	Fred Alger Management LLC	832	$0.26M	0.0%	N/A	0.002%
5/16/2025	Ashton Thomas Private Wealth LLC	4,664	$1.44M	0.1%	+65.4%	0.010%
5/16/2025	Kestra Investment Management LLC	2,242	$0.69M	0.0%	+31.3%	0.005%
5/16/2025	Dynamic Technology Lab Private Ltd	2,812	$0.87M	0.1%	N/A	0.006%
5/16/2025	Talon Private Wealth LLC	5,746	$1.79M	0.2%	+5,823.7%	0.013%
5/16/2025	Rise Advisors LLC	95	$29K	0.0%	-31.2%	0.000%
5/16/2025	Parkman Healthcare Partners LLC	10,232	$3.15M	0.4%	-72.7%	0.023%
5/16/2025	Nissay Asset Management Corp Japan ADV	5,235	$1.61M	0.0%	+0.8%	0.012%
5/16/2025	NewEdge Advisors LLC	854	$0.26M	0.0%	-71.8%	0.002%
5/16/2025	Nitorum Capital L.P.	78,047	$24.06M	3.4%	-18.2%	0.173%
5/16/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	6,316	$1.95M	0.0%	-2.0%	0.014%
5/16/2025	Integrated Wealth Concepts LLC	2,000	$0.62M	0.0%	-79.9%	0.004%
5/16/2025	Jacobs Levy Equity Management Inc.	7,934	$2.45M	0.0%	+249.8%	0.018%
5/16/2025	Gotham Asset Management LLC	89,342	$27.54M	0.2%	+46.0%	0.198%
5/16/2025	Hancock Whitney Corp	6,613	$2.04M	0.1%	-14.2%	0.015%
5/16/2025	Eventide Asset Management LLC	47,241	$14.56M	0.3%	-30.3%	0.105%
5/16/2025	Clark Capital Management Group Inc.	94,364	$29.09M	0.2%	-50.2%	0.209%
5/16/2025	Alliancebernstein L.P.	454,983	$140.26M	0.1%	-35.8%	1.009%
5/16/2025	Banque Transatlantique SA	3,000	$0.86M	0.0%	N/A	0.007%
5/16/2025	AQR Capital Management LLC	908,448	$273.31M	0.3%	-6.9%	2.014%
5/16/2025	Advisors Asset Management Inc.	3,892	$1.20M	0.0%	+40.9%	0.009%
5/16/2025	Amundi	350,193	$107.64M	0.0%	+198.8%	0.776%
5/15/2025	Birchview Capital LP	7,500	$2.31M	2.0%	-25.0%	0.017%
5/15/2025	MPM Bioimpact LLC	58,907	$18.16M	3.1%	+156.1%	0.131%
5/15/2025	Federation des caisses Desjardins du Quebec	8,633	$2.66M	0.0%	+12.2%	0.019%
5/15/2025	Palo Alto Investors LP	105,228	$32.44M	6.2%	-32.4%	0.233%
5/15/2025	EP Wealth Advisors LLC	2,184	$0.67M	0.0%	+29.6%	0.005%
5/15/2025	First Financial Bankshares Inc	13,769	$4.25M	0.1%	+0.3%	0.031%
5/15/2025	Royal Bank of Canada	65,789	$20.28M	0.0%	+99.8%	0.146%
5/15/2025	Mubadala Investment Co PJSC	6,404	$1.97M	0.0%	-5.3%	0.014%
5/15/2025	Panagora Asset Management Inc.	19,315	$5.95M	0.0%	+1,710.2%	0.043%
5/15/2025	Vident Advisory LLC	17,741	$5.47M	0.1%	+45.2%	0.039%
5/15/2025	Evergreen Capital Management LLC	12,260	$3.78M	0.1%	+806.8%	0.027%
5/15/2025	The Manufacturers Life Insurance Company	71,761	$22.12M	0.0%	-41.8%	0.159%
5/15/2025	Magnetar Financial LLC	7,988	$2.46M	0.0%	N/A	0.018%
5/15/2025	WPG Advisers LLC	194	$60K	0.1%	N/A	0.000%
5/15/2025	Trexquant Investment LP	8,919	$2.75M	0.0%	N/A	0.020%
5/15/2025	OMERS ADMINISTRATION Corp	8,944	$2.76M	0.0%	+22.4%	0.020%
5/14/2025	B. Metzler seel. Sohn & Co. AG	919	$0.28M	0.0%	-4.3%	0.002%
5/14/2025	CreativeOne Wealth LLC	764	$0.24M	0.0%	+22.6%	0.002%
5/14/2025	Rafferty Asset Management LLC	35,962	$11.09M	0.0%	-5.6%	0.080%
5/14/2025	Epoch Investment Partners Inc.	285,873	$88.13M	0.5%	+26.4%	0.634%
5/14/2025	FORA Capital LLC	9,689	$2.99M	0.3%	+80.4%	0.021%
5/14/2025	Caisse DE Depot ET Placement DU Quebec	477,757	$147.28M	0.3%	+22.5%	1.059%
5/14/2025	Corebridge Financial Inc.	49,306	$15.20M	0.1%	-2.4%	0.109%
5/14/2025	Comerica Bank	184,603	$56.91M	0.2%	+5.7%	0.409%
5/14/2025	MetLife Investment Management LLC	24,775	$7.64M	0.0%	-1.5%	0.055%
5/14/2025	Walleye Capital LLC	649	$0.20M	0.0%	+23.4%	0.001%
5/14/2025	Campbell & CO Investment Adviser LLC	7,502	$2.31M	0.2%	N/A	0.017%
5/14/2025	Broadleaf Partners LLC	9,498	$2.93M	0.8%	-2.0%	0.021%
5/14/2025	Quantitative Investment Management LLC	3,063	$0.94M	0.1%	N/A	0.007%
5/14/2025	Axiom Investors LLC DE	1,621	$0.50M	0.0%	-83.9%	0.004%
5/14/2025	SVB Wealth LLC	105	$32K	0.0%	N/A	0.000%
5/14/2025	APG Asset Management N.V.	1,715	$0.49M	0.0%	-32.6%	0.004%
5/14/2025	Cadence Bank	3,963	$1.22M	0.1%	+1.2%	0.009%
5/14/2025	AlphaQuest LLC	1,674	$0.52M	0.1%	-27.6%	0.004%
5/14/2025	Allstate Corp	1,930	$0.60M	0.0%	+64.1%	0.004%
5/14/2025	1832 Asset Management L.P.	5,272	$1.63M	0.0%	-3.4%	0.012%
5/14/2025	Integrated Investment Consultants LLC	863	$0.27M	0.0%	N/A	0.002%
5/14/2025	Price T Rowe Associates Inc. MD	189,731	$58.49M	0.0%	-52.3%	0.421%
5/14/2025	Partners Capital Investment Group LLP	6,359	$1.96M	0.0%	N/A	0.014%
5/14/2025	Martingale Asset Management L P	16,798	$5.18M	0.1%	-51.5%	0.037%
5/14/2025	Candriam S.C.A.	79,213	$24.42M	0.2%	+6.2%	0.176%
5/14/2025	TFB Advisors LLC	3,046	$0.94M	0.3%	+34.7%	0.007%
5/14/2025	Capital Fund Management S.A.	24,061	$7.42M	0.0%	-40.2%	0.053%
5/14/2025	Erste Asset Management GmbH	39,295	$12.08M	0.2%	-16.6%	0.087%
5/14/2025	Credit Agricole S A	8,466	$2.60M	0.0%	-2.2%	0.019%
5/14/2025	BI Asset Management Fondsmaeglerselskab A S	83,866	$25.85M	0.3%	-1.6%	0.186%
5/14/2025	Hsbc Holdings PLC	179,706	$55.36M	0.0%	-12.3%	0.398%
5/14/2025	Fuller & Thaler Asset Management Inc.	491,127	$151.40M	0.6%	-7.8%	1.089%
5/14/2025	Quantbot Technologies LP	1,862	$0.57M	0.0%	+5,072.2%	0.004%
5/14/2025	Wellington Management Group LLP	2,026,416	$624.68M	0.1%	-17.8%	4.492%
5/14/2025	Korea Investment CORP	49,389	$15.23M	0.0%	+25.7%	0.109%
5/13/2025	Qtron Investments LLC	1,754	$0.54M	0.1%	+131.7%	0.004%
5/13/2025	Northern Trust Corp	471,365	$145.31M	0.0%	-3.6%	1.045%
5/13/2025	Brooklyn Investment Group	193	$59K	0.0%	+103.2%	0.000%
5/13/2025	Northwest & Ethical Investments L.P.	5,416	$1.67M	0.0%	+42.0%	0.012%
5/13/2025	Raymond James Financial Inc.	55,545	$17.12M	0.0%	+7.3%	0.123%
5/13/2025	Cresset Asset Management LLC	8,687	$2.68M	0.0%	+1.3%	0.019%
5/13/2025	State of New Jersey Common Pension Fund D	13,997	$4.32M	0.0%	-9.3%	0.031%
5/13/2025	American Century Companies Inc.	38,320	$11.81M	0.0%	+0.4%	0.085%
5/13/2025	Brandywine Global Investment Management LLC	27,310	$8.42M	0.1%	+0.7%	0.061%
5/13/2025	Element Capital Management LLC	8,772	$2.70M	0.7%	N/A	0.019%
5/13/2025	Dimensional Fund Advisors LP	624,711	$192.57M	0.0%	+0.7%	1.385%
5/13/2025	Fox Run Management L.L.C.	6,129	$1.89M	0.3%	+404.0%	0.014%
5/13/2025	Lord Abbett & CO. LLC	243,921	$75.19M	0.3%	+12.6%	0.541%

Data available starting January 2016

See Full Table

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for treating high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, the company engages in developing RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.

Today's Range

Now: $316.34

$314.27

$320.48

50 Day Range

MA: $299.49

$278.89

$320.37

52 Week Range

Now: $316.34

$266.98

$417.82

Volume

886,326 shs

Average Volume

443,403 shs

Market Capitalization

$14.27 billion

P/E Ratio

13.89

Dividend Yield

N/A

Beta

0.58

Who are the company insiders with the largest holdings of United Therapeutics?: United Therapeutics' top insider shareholders include:
Paul A Mahon (EVP)
Tommy G Thompson (Director)
James Edgemond (CFO)
Nilda Mesa (Director)
Judy D Olian (Director)
Louis W Sullivan (Director)
Christopher Causey (Director)
Michael Benkowitz (COO)
Raymond Dwek (Director)
Martine A Rothblatt (CEO)
Martine A Rothblatt (Director)
Christopher Patusky (Director)
Learn More about top insider investors at United Therapeutics.
Who are the major institutional investors of United Therapeutics?: United Therapeutics' top institutional investors include:
Vanguard Group Inc. — 9.88%
Wellington Management Group LLP — 4.49%
AQR Capital Management LLC — 2.01%
LSV Asset Management — 2.00%
Dimensional Fund Advisors LP — 1.38%
Pacer Advisors Inc. — 1.22%
Learn More about top institutional investors of United Therapeutics stock.
Which major investors are selling United Therapeutics stock?: In the last quarter, UTHR stock was sold by these institutional investors:
Wellington Management Group LLP
Alliancebernstein L.P.
Price T Rowe Associates Inc. MD
Clark Capital Management Group Inc.
AQR Capital Management LLC
The Manufacturers Life Insurance Company
Palo Alto Investors LP
Pacer Advisors Inc.
In the last year, company insiders that have sold United Therapeutics company stock include:
Paul A Mahon (EVP)
Tommy G Thompson (Director)
James Edgemond (CFO)
Nilda Mesa (Director)
Judy D Olian (Director)
Louis W Sullivan (Director)
Christopher Causey (Director)
Michael Benkowitz (COO)
Raymond Dwek (Director)
Martine A Rothblatt (CEO)
Learn More investors selling United Therapeutics stock.
Which major investors are buying United Therapeutics stock?: Within the last quarter, UTHR stock was purchased by institutional investors including:
Vaughan Nelson Investment Management L.P.
Nuveen LLC
Amundi
GAMMA Investing LLC
Acadian Asset Management LLC
Invesco Ltd.
Natixis Advisors LLC
AustralianSuper Pty Ltd